These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35806381)

  • 21. Roles of FGFR in oral carcinogenesis.
    Xie X; Wang Z; Chen F; Yuan Y; Wang J; Liu R; Chen Q
    Cell Prolif; 2016 Jun; 49(3):261-9. PubMed ID: 27218663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reprogramming of fatty acid metabolism in cancer.
    Koundouros N; Poulogiannis G
    Br J Cancer; 2020 Jan; 122(1):4-22. PubMed ID: 31819192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glioma Cell Secretion: A Driver of Tumor Progression and a Potential Therapeutic Target.
    Almiron Bonnin DA; Havrda MC; Israel MA
    Cancer Res; 2018 Nov; 78(21):6031-6039. PubMed ID: 30333116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma.
    Chakraborty S; Lakshmanan M; Swa HL; Chen J; Zhang X; Ong YS; Loo LS; Akıncılar SC; Gunaratne J; Tergaonkar V; Hui KM; Hong W
    Nat Commun; 2015 Jan; 6():6184. PubMed ID: 25630468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
    Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
    J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGF-β signaling in cancer.
    Gu S; Feng XH
    Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):941-949. PubMed ID: 30165534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting.
    Xu M; Wang Y; Xia R; Wei Y; Wei X
    Cell Prolif; 2021 Oct; 54(10):e13115. PubMed ID: 34464477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SPAG5: An Emerging Oncogene.
    He J; Green AR; Li Y; Chan SYT; Liu DX
    Trends Cancer; 2020 Jul; 6(7):543-547. PubMed ID: 32291236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor Suppressors Having Oncogenic Functions: The Double Agents.
    Datta N; Chakraborty S; Basu M; Ghosh MK
    Cells; 2020 Dec; 10(1):. PubMed ID: 33396222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting transcription factor STAT3 for cancer prevention and therapy.
    Chai EZ; Shanmugam MK; Arfuso F; Dharmarajan A; Wang C; Kumar AP; Samy RP; Lim LH; Wang L; Goh BC; Ahn KS; Hui KM; Sethi G
    Pharmacol Ther; 2016 Jun; 162():86-97. PubMed ID: 26478441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Sixth George Swanson Christie Memorial Lecture: growth factors and their receptors: new opportunities for cancer treatment.
    Burgess AW; Thumwood CM
    Pathology; 1994 Oct; 26(4):453-63. PubMed ID: 7892049
    [No Abstract]   [Full Text] [Related]  

  • 32. Linking oncogenic pathways with therapeutic opportunities.
    Bild AH; Potti A; Nevins JR
    Nat Rev Cancer; 2006 Sep; 6(9):735-41. PubMed ID: 16915294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis.
    Heldin CH; Lennartsson J; Westermark B
    J Intern Med; 2018 Jan; 283(1):16-44. PubMed ID: 28940884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNAi screens in mice identify physiological regulators of oncogenic growth.
    Beronja S; Janki P; Heller E; Lien WH; Keyes BE; Oshimori N; Fuchs E
    Nature; 2013 Sep; 501(7466):185-90. PubMed ID: 23945586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical role of the fibroblast growth factor signalling pathway in Ewing's sarcoma octamer-binding transcription factor 4-mediated cell proliferation and tumorigenesis.
    Kim J; Kim HS; Shim JJ; Lee J; Kim AY; Kim J
    FEBS J; 2019 Nov; 286(22):4443-4472. PubMed ID: 31155838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell signalling: Even kinase-inactive BRAF is oncogenic.
    Killock D
    Nat Rev Clin Oncol; 2017 Nov; 14(11):648-649. PubMed ID: 28857078
    [No Abstract]   [Full Text] [Related]  

  • 37. Signal transduction pathways: the molecular basis for targeted therapies.
    Ethier SP
    Semin Radiat Oncol; 2002 Jul; 12(3 Suppl 2):3-10. PubMed ID: 12174339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenes in melanoma.
    Polsky D; Cordon-Cardo C
    Oncogene; 2003 May; 22(20):3087-91. PubMed ID: 12789285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copper metabolism as a unique vulnerability in cancer.
    Shanbhag VC; Gudekar N; Jasmer K; Papageorgiou C; Singh K; Petris MJ
    Biochim Biophys Acta Mol Cell Res; 2021 Feb; 1868(2):118893. PubMed ID: 33091507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of cell signalling pathways.
    Langdon SP; Smyth JF
    Cancer Treat Rev; 1995 Jan; 21(1):65-89. PubMed ID: 7859227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.